Journal article
M. Montera, A. Goins, Leos Cmarko, N. Weiss, Karin N Westlund High, Sascha R. A. Alles
Channels, 2021
Channels, 2021
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Montera, M., Goins, A., Cmarko, L., Weiss, N., High, K. N. W., & Alles, S. R. A. (2021). Trigeminal neuropathic pain is alleviated by inhibition of Cav3.3 T-type calcium channels in mice. Channels.
Chicago/Turabian
Click to copy
Montera, M., A. Goins, Leos Cmarko, N. Weiss, Karin N Westlund High, and Sascha R. A. Alles. “Trigeminal Neuropathic Pain Is Alleviated by Inhibition of Cav3.3 T-Type Calcium Channels in Mice.” Channels (2021).
MLA
Click to copy
Montera, M., et al. “Trigeminal Neuropathic Pain Is Alleviated by Inhibition of Cav3.3 T-Type Calcium Channels in Mice.” Channels, 2021.
BibTeX Click to copy
@article{m2021a,
title = {Trigeminal neuropathic pain is alleviated by inhibition of Cav3.3 T-type calcium channels in mice},
year = {2021},
journal = {Channels},
author = {Montera, M. and Goins, A. and Cmarko, Leos and Weiss, N. and High, Karin N Westlund and Alles, Sascha R. A.}
}
Abstract
ABSTRACT In this brief report, we demonstrate that the Cav3.3 T-type voltage-gated calcium channel subtype is involved in our FRICT-ION model of chronic trigeminal neuropathic pain. We first showed that the Cacna1i gene encoding Cav3.3 is significantly upregulated in whole trigeminal ganglia of FRICT-ION mice compared to controls at week 10 post-injury. We confirmed protein upregulation of Cav3.3 compared to controls using Western blot analysis of whole trigeminal ganglia tissues. Finally, we demonstrated that intraperitoneal injection of a selective TAT-based Cav3.3 blocking peptide in FRICT-ION mice significantly reduces Cav3.3 protein expression at the peak anti-allodynic effect (4 hrs post-injection) of the attenuated neuropathic pain behavior. We also suggest that blockade of Cav3.3 may be more effective in attenuating trigeminal neuropathic pain in female than male FRICT-ION mice. Therefore, blocking or attenuating Cav3.3 function may be an effective strategy for the treatment of trigeminal neuropathic pain.
